Interview on Antibiotic Resistance Panel
Dr. Jack Regan discusses LexaGene’s development of an antibiotic resistance panel to detect antibiotic resistance in pathogens in just one hour.
LexaGene HQ Tour
Take a short virtual tour of LexaGene and get an inside look at our state-of-the-art facilities.
LX2 Unveiling at AAVLD
LexaGene unveiled the LX2 prototype design to a veterinary diagnostics audience on October 20th, 2018 at the AAVLD Annual Meeting in Kansas City. LX2 Prototype design; Unveiling at Booth 203 by CEO Dr. Jack Regan; Veterinary diagnosticians engaging with LX2 technology.
Interview – Proactive Investors
Daryl Rebeck featured on Proactive Investors with Steve Darling at the LD Micro event on September 4, 2018.
Pinnacle Digest Podcast
Pinnacle Digest recently featured LexaGene in a podcast showcasing LexeGene’s new state-of-the-art labs and speaking with CEO Jack Regan.
LexaGene on Capital Ideas TV
Capital Ideas TV recently featured LexaGene CEO Jack Regan to discuss plans for commercialization of the LX6 system.
Daryl Rebeck on BNN
LexaGene President Daryl Rebeck featured on Capital Ideas TV, which aired on BNN 25 Feb 2018.
Top 50 TSX.V Company
LexaGene is honored to be named a Top 50-Ranked TSX Venture company. Watch CEO Jack Regan’s interview with the TSX Venture Exchange
LX6 Technical Overview Video
LexaGene describes the technology behind our fully automated, open access pathogen detection device, the LX6.
LexaGene on FOX Biz TV
LexaGene was featured on Innovations with Ed Begley Jr. which aired on Fox Business Network 8/26 and 9/9, 2017. Learn more about LexaGene by watching the segment.
Introducing the LX6
At a conference in July 2017, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market.